Lu HY - Search Results

1

Assessment of prognosis and curative effect in patients with chronic severe hepatitis using the model for end-stage liver disease scores.

Wu CH, Tian GS, Xu XY, Yu YY, Lu HY. Wu CH, et al. Among authors: lu hy. Chin Med J (Engl). 2006 Jan 20;119(2):148-50. Chin Med J (Engl). 2006. PMID: 16454997 No abstract available.

2

Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.

Bai L, Feng ZR, Lu HY, Li WG, Yu M, Xu XY. Bai L, et al. Among authors: lu hy. Chin Med J (Engl). 2009 Jan 5;122(1):5-9. Chin Med J (Engl). 2009. PMID: 19187609

3

Prevalence of abnormal glycometabolism in patients with chronic hepatitis C and related risk factors in China.

Wang LF, Wu CH, Shan Y, Fan XH, Huo N, Lu HY, Xu XY. Wang LF, et al. Among authors: lu hy. Chin Med J (Engl). 2011 Jan;124(2):183-8. Chin Med J (Engl). 2011. PMID: 21362362

4

[The effect of cryoglobulinemia on the antiviral therapy in patients with chronic hepatitis C].

Fan XH, Wang LF, Liu LC, Yao Y, Shan Y, Lu HY, Wu CH, Xu XY, Wei L. Fan XH, et al. Among authors: lu hy. Zhonghua Gan Zang Bing Za Zhi. 2011 Oct;19(10):721-5. doi: 10.3760/cma.j.issn.1007-3418.2011.10.001. Zhonghua Gan Zang Bing Za Zhi. 2011. PMID: 22409840 Chinese.

5

Efficacy of pegylated interferon-alpha-2a plus ribavirin for patients aged at least 60 years with chronic hepatitis C.

Zheng YY, Fan XH, Wang LF, Tian D, Huo N, Lu HY, Wu CH, Xu XY, Wei L. Zheng YY, et al. Among authors: lu hy. Chin Med J (Engl). 2012 Jun;125(11):1852-6. Chin Med J (Engl). 2012. PMID: 22884041

6

Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients.

Fan XH, Wu CH, Wang LF, Zheng YY, Yao Y, Lu HY, Xu XY, Wei L. Fan XH, et al. Among authors: lu hy. Chin Med J (Engl). 2012 Nov;125(22):4014-7. Chin Med J (Engl). 2012. PMID: 23158135

7

[Clinical and pathological analysis of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome].

Wu CH, Xu XY, Lu HY, Yu YY, Wang GQ. Wu CH, et al. Among authors: lu hy. Beijing Da Xue Xue Bao Yi Xue Ban. 2004 Dec;36(6):609-11. Beijing Da Xue Xue Bao Yi Xue Ban. 2004. PMID: 15605092 Free article. Chinese.

8

Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.

Lu HY, Zhuang LW, Yu YY, Ivan H, Si CW, Zeng Z, Li J, Hou DM, Chen XY, Han ZH, Chen Y. Lu HY, et al. World J Gastroenterol. 2007 May 28;13(20):2878-82. doi: 10.3748/wjg.v13.i20.2878. World J Gastroenterol. 2007. PMID: 17569128 Free PMC article. Clinical Trial.

9

[Establishment and application of a real-time PCR method to detect hepatitis B virus cccDNA quantitatively].

Zhuang LW, Lu HY, Yu YY, Si CW, Yu M, Zhang NL, Gong WB. Zhuang LW, et al. Among authors: lu hy. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007 Jun;21(2):182-4. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2007. PMID: 17653331 Chinese.

10

[Effects of antiviral agents on intrahepatic ccc DNA in HBeAg-positive chronic hepatitis B patients].

Lu HY, Zhuang LW, Yu YY, Si CW, Li J. Lu HY, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Mar;16(3):198-202. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 18364079 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

666 results

Search Page

Filters